key: cord-0718939-ukth0efs
authors: Martinez, Ryan John; Pankratz, Nathan; Schomaker, Matthew; Daniel, Jerry; Beckman, Kenneth; Karger, Amy Beth; Thyagarajan, Bharat; Ferreri, Patricia; Yohe, Sophia Louise; Nelson, Andrew Cook
title: Prediction of false positive SARS-CoV-2 molecular results in a high-throughput open platform system
date: 2021-06-08
journal: J Mol Diagn
DOI: 10.1016/j.jmoldx.2021.05.015
sha: 933de79c9754845979b350d2e9aa62004ad5482d
doc_id: 718939
cord_uid: ukth0efs

Widespread high-throughput testing for identification of SARS-CoV-2 infection by RT-PCR has been a foundation in the response to the COVID-19 pandemic. Quality assurance metrics for these RT-PCR tests are still evolving as testing becomes widely implemented. As testing increases, it is important to understand performance characteristics and the errors associated with these tests. Here, we investigate a high-throughput, laboratory developed SARS-CoV-2 RT-PCR assay to determine if modeling can generate quality control metrics that identify false positive (FP) results due to contamination. This study reviewed repeated clinical samples focusing on positive samples that test negative upon re-extraction and PCR, likely representing false positives. To identify and predict false positive samples, we constructed machine learning derived models based on the extraction methodology used. These models identified variables associated with false positive results across all methodologies, with sensitivities for predicting FP results ranging between 67-100%. Application of the models to all results predicted a total FP rate of 0.08% across all samples, or 2.3% of positive results, similar to reports for other RT-PCR tests for RNA viruses. These models can predict quality control parameters, enabling laboratories to generate decision trees that reduce interpretation errors, allow for automated reflex testing of samples with a high FP probability, improve workflow efficiency and increase diagnostic accuracy for patient care.

The COVID-19 pandemic created the need to rapidly implement high-throughput, widespread testing in the United States. The primary method for detecting SARS-CoV-2, the RNA virus responsible for COVID-19, is reverse transcriptase polymerase chain reaction (RT-PCR). RT-PCR is currently widely used and is the gold-standard for the diagnosis of many infectious diseases 1 . RT-PCR has become the predominate diagnostic modality for viral disease as results are rapidly returned, it demonstrates high specificity and sensitivity and it is relatively inexpensive 2 . However, as COVID-19 cases spread, it was quickly apparent that the need for testing outpaced health departments and clinical laboratories ability to provide testing. Thus, a multitude of RT-PCR and transcription mediated amplification (TMA) assays testing for SARS- Guidelines for SARS-CoV-2 testing have been released by working groups and mainly focus on clinical scenarios of when to employ testing 3 . Many SARS-CoV-2 clinical tests receiving EUA only have interpretation guidelines for persons under investigation (PUI), or those patients with an increased pretest probability of COVID-19 disease. Most of these same tests have not been validated as a screening technique for mildly symptomatic or asymptomatic patients, even though they are widely used in this manner. Testing of asymptomatic patients is a cornerstone for combating the spread of SARS-CoV-2 because transmission can be facilitated J o u r n a l P r e -p r o o f by patients with minimally or pre-symptomatic infections 4 . As these tests have not been fully studied in the setting of minimally symptomatic individuals, there is a potential for resultant errors. Attributing a positive SARS-CoV-2 result to an asymptomatic patient has an impact on the mental health, physical health and socioeconomic wellbeing of that patient. A positive result also has wide-ranging impacts on infection control measures in the healthcare system and the community, such as isolation procedures in the hospital, closure of schools and daycares, and the halting of nursing home visits. In a low prevalence population with low pre-test probability, there is increased concern that a positive result is an error and represents a false-positive result. Additionally, a false positive SARS-CoV-2 result (FP, defined as a non-reproducible result on repeat extraction and RT-PCR) in a patient with significant symptoms due to other causes, such as a congestive heart failure patient with acutely worsening shortness of breath and cough, could lead to improper medical management. Thus, there is a need to understand error rates of SARS-CoV-2 assays to reduce the risk of false results. External quality assessments (EQAs) are traditionally performed on molecular assays by providing clinical laboratories with positive and negative samples and determining FP and false negative (FN) rates from these blinded tests. FN results due to poor nasopharyngeal sampling or changes in anatomical viral replication have been identified and discussed elsewhere 5 . However, a recent study analyzing EQAs for RNA virus detection found FP rates ranged from 0% up to 16.7%, with a median of 2.3% 6 . Therefore, it is highly likely a small portion of SARS-CoV-2 RT-PCR positive results are FPs and should be investigated.

As the need for SARS-CoV-2 testing was increasing, shortages of testing supplies developed. Thus, our clinical lab established a high-throughput, open platform SARS-CoV-2 assay using the CDC developed primers and probes that could be easily adapted for multiple extraction methodologies 7 . To study FP results across multiple extraction systems, clinical samples with concern for contamination or those with low viral load, as defined by late cycle threshold (Ct), underwent repeat extraction and testing from the primary sample. In general, FP J o u r n a l P r e -p r o o f results from PCR may be due to testing the wrong sample (due to mislabeling, sample mix-up, or reporting errors), cross-reactivity of the PCR assay, or contamination. Contamination is of particular concern in an open platform assay when aerosolization from human or machine handling can cause the transfer of target genomic material between wells, especially when there are true positive (TP, defined as reproducible results on repeat extraction and RT-PCR) samples that can exhibit as much a 10 6 range in virus quantity. Results of initial and repeat testing were compared to determine if there were discordant results on repeat. Initially positive samples that were discordant were considered FP, while concordant samples were considered TP. Next, machine learning derived models were generated taking into account the relative viral load of the index sample, the extraction methodology and relative viral load of surrounding positive wells. These models were used as a clinical decision support tool to identify wells with a high probability of being a FP and to identify technical contributors to FP samples. Modeling identified FP samples that could be predicted across different extraction methodologies, with each model identifying different variables used to make FP predictions. From these models we can identify potential technical improvements as well as identify samples with a high probability of FP results to act as an adjunct for laboratory clinical decision making and initiate automated sample re-extraction and repeat.

Detection of SARS-CoV-2 RNA by RT-PCR has been detailed previously 7 . Individual RT-PCR reactions were performed in a 384-well plate using the United States Centers for Disease Control-designed primers and probes specific for the N1, N2 regions of the SARS-CoV-2 virus and human RNase P (RP). Nucleic acid extractions were performed using: a) manual, column- 2D-barcoded tubes arranged in two rows of 8 samples for transport to the physically separate PCR setup facility; there samples were opened with automated instrumentation and transferred into 96-well plates (combining six extraction batches of 16 samples) using automation-assisted pipetting instruments. Automation-assisted pipetting instruments were then used to aliquot a 384-well PCR assay plate from the 96-well sample master plates. For the automated extraction processes using KingFisher or Zymo kits, racks of 93 primary nasopharyngeal samples plus three controls were manually transferred in a BSC into 96 well plates for viral inactivation, and then placed on the automated RNA extraction instrument to complete the procedure. Following completion of automated extraction, plates were sealed and transferred to the physically separate PCR setup facility; there, 96-well plates were unsealed and used for 384-well PCR J o u r n a l P r e -p r o o f assay plate set up as above. The assay limit of detection is between 500-1600 viral copies per milliliter with minor variation between extraction methods. 500 viral copies correlated to Ct values of between 37-37.5 across 20 replicates performed using the EUA protocols (Data not shown).

For studies on follow up testing after a predicted or repeated FP result, PCR results were performed by one of four tests: the CDC N1/N2 PCR test described above, Xpert Xpress SARS-CoV-2 PCR assay (Cepheid, Sunnyvale, CA), Aptima SARS-CoV-2 TMA assay (Hologic, Marlborough, MA), or Simplexa SARS-CoV-2 PCR assay (DiaSorin, Cypress, CA). All tests were performed as per manufacturer instructions.

Results were initially interpreted by an automated algorithm following CDC and FDA recommendations as follows: Pathologists reviewed all auto-generated positive, inconclusive and invalid results and multicomponent plots to confirm data quality and result interpretation; this review determined the need for repeat analysis based on data quality or plate layouts indicating proximity of other positive samples. Inconclusive results with multicomponent plots demonstrating exponential amplification above a positive threshold (normalized reporter value >0.5) with no concern for contamination were not repeated and resulted as positive as per FDA recommendations.

Positive or inconclusive samples with concern for contamination were re-extracted and repeated. Open platform testing can be more prone to contamination of viral products due to aerosolization, plate seal removal or pipettor drag during extraction or PCR setup 8 if there was concern for contamination from surrounding wells as indicated by a low relative viral load (RVL; see below for calculation) in the index well and high RVL in surrounding wells. Low RVL was defined at approximately less than 0.015 (-1.80 after log 10 transformation), which correlates with a N1/N2 Ct values of 34 and an RP Ct value of 28. RP Ct of 28 was selected as it was approximately the average value, and the N1/N2 Ct 34 value was empirically as it was approximately 50-fold less abundant than RP. Extraction methodology was also taken into account when selecting wells for repeat as manual and automated extractions empirically demonstrated different patterns of potential contamination in early quality control analyses (see Supplemental Figure S1 ). Inconclusive samples with poor amplification identified by multicomponent plot review were re-extracted and repeated. Negative samples with RP Ct between 38-40 are re-extracted once to confirm the negative result. All invalid results were repeated once.

Multiple datasets were generated from the analysis of the raw PCR data. The raw dataset was first parsed for technically valid runs with no errors. Next, RVL was calculated for all autoscored positive and inconclusive samples (as defined by the interpretation algorithm described above) using the following formula: (2 (RP Ct-N1 Ct) + 2 (RP Ct-N2 Ct) )/2. This formula provides a normalized relative value of the amount of viral RNA in comparison to total human nucleic acid within each sample and was adapted from previous reports showing normalization was needed for reliable estimation of viral load across multiple samplings 9 . The formula used was adapted in order to incorporate both the N1 and N2 measurements as well as transform the Ct data to a linear scale. Next, geographical parameters were calculated that included east-west RVL, northsouth RVL, surrounding RVL and diagonal RVL (Supplemental Figure S1 ). For the primary dataset, samples were grouped based on their unique sample identification number and parsed for only the first PCR result auto-called using the interpretation algorithm described above. Thus, the primary dataset represents the preliminary test result generated by automated result classification without technologist or pathologist review for data quality and contamination potential before any human-determined repeat analysis was performed. For the final resulting dataset, samples were grouped based on their unique sample identification number and parsed for the final pathologist-reviewed result, which included the final result for samples subjected to repeat extraction and analysis. To generate the repeated dataset, the cleaned dataset was parsed and filtered specifically for samples that were repeated following re-extraction and linked by the unique sample identification number. Samples that underwent repeat PCR without repeated extraction were excluded from the analysis, as these J o u r n a l P r e -p r o o f were mostly due to PCR reaction anomalies unrelated to concern for contamination. To generate the modeling dataset from the repeated dataset, we reclassified any result initially auto-called as inconclusive in the primary dataset to positive, because the modeling approach Table S1 ).

Testing with our laboratory-developed RT-PCR assay for detection of SARS- Figure   1A ). By August, up to 6,000 tests were performed daily. As testing volume increased, the prevalence of positive SARS-CoV-2 tests decreased from ~10-20% positivity to ~1.0-1.5% by early July, but then began to increase to ~5% in late July ( Figure 1B) On retrospective data review, extraction methods for 54 repeated samples (4 positive samples, 1 sample with no reaction, 46 not detected) were not identified. These samples were removed from modeling analysis but are present in the total data set. The most common reason samples were repeated following automated extraction were invalid primary results while the most common reasons samples were repeated following manual extraction was inconclusive primary results ( Table 2) . Analysis comparing TP and FP results demonstrated significantly more FP events when initial manual extraction methods were used (Fischer's exact test, P<0.0001) ( Figure 2A , B, Table 3 ). Thus, FP events are identified in the SARS-CoV-2 PCR assay and are generated at different rates across extraction methodologies.

We hypothesized that samples with initial positive/inconclusive results returning negative results on repeat are likely FP events due to contamination; however, some samples could represent an initial TP and repeat FN due to poor sample quality or inconsistent detection of low-concentration SARS-CoV-2 RNA. We used our data to evaluate for these two possibilities.

First, if the FP events were associated with poor sample collection, the FPs would demonstrate repeat. Our basic assumptions were that wells directly surrounding a sample were most likely to contribute to contamination and that the relative difference in viral concentration between samples would impact the probability of a FP result. Due to technical differences across the three extraction methods, we hypothesized that certain directional relationships between neighboring samples could be more prominent contributors to the manner of contamination.

Based on these assumptions, we defined 12 different variables (Supplemental Table S2 and Supplemental Figure S1 ) for analysis and modeled data from each of the three extraction methodologies separately. The models' predictions showed a positive predictive rate of 87%, 93% and 65% for detecting FPs using the manual, automated-KingFisher and automated-Tecan extraction methods, respectively ( Figure 3A , B, C). Sensitivity of the models for the three extraction methods were 96%, 100% and 67%, while the specificity was only 36%, 90% and 66%, respectively ( Figure 3A , data look similar, N2 carries more weight in predicting FP than N1 in the model. Next, twodimensional partial dependency plots were created to investigate how two variables interacted within the prediction models ( Figure 5H) 

Using data generated from repeated samples on an LDT high throughput test, we developed models to predict false positive SARS-CoV-2 PCR results and generate QC metrics for individual extraction methodologies. Employment of these models and identified variables will be used to improve the assay, as well as support clinical decision making when performing data quality review of results. Specifically, the manual extraction model identified high relative viral loads within each 16-sample extraction batch as a potential source of contamination. As 

RJM analyzed and interpreted the data and wrote the manuscript. NP contributed to data analysis and interpretation and edited the manuscript. MS contributed to acquisition and interpretation of data and discussed design of the manuscript. JD contributed to acquisition and interpretation of data and discussed design of the manuscript. KBB contributed to study conception and design, data acquisition, and edited the manuscript. PF, ABK and BT contributed to interpretation of data and edited the manuscript. SY contributed to study conception and design and edited the manuscript. ACN contributed to study conception and design, interpreted data and wrote the manuscript.

ACN is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. 

Interpreting Diagnostic Tests for SARS-CoV-2

Real-time PCR in virology

Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications

Diagnosing SARS-CoV-2 infection: the danger of over-reliance on positive test results

Analytical Validation of a COVID-19 qRT-PCR Detection Assay Using a 384-well Format and Three Extraction Methods, bioRxiv 2020

Real-time PCR in clinical microbiology: applications for routine laboratory testing

Pandemic A(H1N1)2009 time RT-PCR: Is viral quantification useful?

Building Predictive Models in R Using the caret Package

pdp: An R Package for Constructing Partial Dependence Plots

Quantifying and Understanding Well-to-Well Contamination in Microbiome Research

Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: Analytical and epidemiologic approaches

Virological assessment of hospitalized patients with COVID-2019

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Identification of SARS-CoV-2 in a proficiency testing program

Digital pathology and artificial intelligence

Deep Learning to Assess Long-term Mortality from Chest Radiographs

J o u r n a l P r e -p r o o f